Rahul Mohan

General Practitioner, with special interest in Diabetes & CVRM; SCOPE certified. views are my own

[Rahul Mohan @rahmoh1]

@parthaskar May God almighty give strength to you and to your family to bear this irreparable loss🙏🙏🙏

[PCDO Society @pcdosociety]

Yesterday’s away day was a great opportunity for the PCDO Society team to step back, reflect, and focus on what’s ahead.

We had productive discussions shaping our strategy and mapping out a 3-year plan to strengthen our impact and support our community.

Excited about what’s to come and the direction we’re heading in - watch this space. 🚀

#Strategy #Planning #Teamwork #PCDOSociety

[Rahul Mohan @rahmoh1]

Staging prediabetes and type 2 diabetes: the time to start is now - The Lancet Diabetes & Endocrinology https://t.co/VqfZi3oRnN

[Rahul Mohan @rahmoh1]

We talk about staging in number of MLTCs but not in Type 2 diabetes & Prediabetes(Non-diabetic Hyperglycamia). Time has come for HCPs working in Primary Care to start looking into this when prevention strategy is to be implemented. @pcdosociety. Prof Viral Shah #ATTD2026

[Rahul Mohan @rahmoh1]

This is an interesting read on the changing landscape of Atherosclerotic disease. Factors which contribute here are not going surprise us. Clinical inertia when dealing with patients with MLTCs.

[The Lancet @TheLancet]

"We must reflect on current prevention strategies in the context of the changing contribution of different cardiovascular conditions."

Nathalie Conrad & colleagues explore the evolving spectrum of cardiovascular disease: https://t.co/MgCo3uMiB4

[Scott Isaacs @scottisaacsmd]

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.
https://t.co/EK4grAzJu4

[PCDO Society @pcdosociety]

Rahul Mohan explores the importance of a patient-centred approach in obesity as well as type 2 diabetes.
❓Are BMI and percentage weight loss still the right way to measure success in weight management?
❓What role should patient-reported outcomes play in our approach?

[Rahul Mohan @rahmoh1]

I have been featured in a recent NICE Guidelines article exploring important inequalities in access to SGLT2 inhibitors for people living with type 2 diabetes.

Proud to contribute to this important conversation.

You can read the full article here: https://t.co/Vem3KdT1ta

[Scott Isaacs @scottisaacsmd]

Breaking! The FDA has approved Wegovy #semaglutide to treat #MASH in adults with moderate-to-advanced fibrosis.
https://t.co/NY62l47vo4

[PCDO Society @pcdosociety]

Elections to the PCDO Society committee are in November. Help steer the Society! This year, we are particularly seeking applications from the NURSING PROFESSION.

https://t.co/mgd6JPKnEs

[Prof Kamlesh Khunti @kamleshkhunti]

Just read the 10 year Health Plan for England

Great to see commitment to research & innovation

Mentions research 100 times and innovation 99 times

As a GP, thrilled to see emphasis on Neighbourhood Health Services

Bringing care closer to communities

https://t.co/Om5jLXIuOv

[Prof Kamlesh Khunti @kamleshkhunti]

Why Do Patients Discontinue GLP-1 Medications for Obesity?

Adherence Challenges
❌ 50% stop treatment within 6 months

Top Reasons for Stopping
🤢 Side effects (mainly GI): 36%
🚗 Logistics (travel, time): 24%
💰 Cost & affordability: 23%

https://t.co/g1ucNoteNH

[PCDO Society @pcdosociety]

Rahul Mohan and David Miller outlining the principal concerns in a case of early-onset type 2 diabetes — and how to manage them

[Rahul Mohan @rahmoh1]

@scottisaacsmd The impact which the lack of sleep has on metabolic health has largely been unrecognised. Completely agree with this classification of being a metabolic disorder. Hope this draws attention of the HCPs who should begin to address this.

[Scott Isaacs @scottisaacsmd]

Honored to be an author-alongside so many prestigious coauthors-on this important work tackling obesity in primary care. https://t.co/kn41fPSBkt

[Rahul Mohan @rahmoh1]

Nottingham has had its guidelines approved for the Management of Chronic Kidney Disease (CKD) for Adults. This has relevance for Primary Care in Nottingham and Nottinghamshire.

Hard work begins now for the implementation in Primary Care - Early identification is key. @NICEComms

https://t.co/kWur1yapiX

[Rahul Mohan @rahmoh1]

@parthaskar @Jazzsethi95 @RenzaS @drmohanv @AskDrShashank @riddhimodi @NupurLalvani @Rezaidi @Type1Adventures @DigiBeteUK @drpratikc @dedocORG Congratulations Jazz. Stay happy and blessed.

[SAHF.ORG.UK @SouthAsianHF]

Join @amibanerjee1 as he discusses ethnic health inequalities research, addressing the “known unknowns” and “unknown unknowns.” Learn how to address these gaps to build better health outcomes by registering today https://t.co/hMXcHtxsJV #HealthEquity

[SAHF.ORG.UK @SouthAsianHF]

Register to hear Prof Sir Nilesh Samani discuss the limitations of current clinical risk scores for cardiovascular disease and explore if polygenic risk scores can improve risk prediction. Don’t miss the latest findings in genetic CVD research! https://t.co/hMXcHtxsJV

[SAHF.ORG.UK @SouthAsianHF]

*Volunteers needed*
Vitamin D is important for our immune system, but food alone isn’t enough. Especially in winter & for the South Asian & Black African/Caribbean communities! Should Vit D intakes vary based on ethnicity? Email Emily Brown to get involved [email protected]